Bristol-Myers wins bragging rights over IBM
The US corporate bond market caught fire this week, as two huge M&A financings - $19bn for Bristol-Myers Squibb and $20bn for IBM - were priced on successive days, and met contrasting fortunes.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: